Back to Journals » Journal of Hepatocellular Carcinoma » Volume 2
Original Research
Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,955 | Dovepress* | 9,495+ | 1,036 | 10,531 | |
PubMed Central* | 460 | 69 | 529 | ||
Totals | 9,955 | 1,105 | 11,060 | ||
*Since 22 June 2015 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 1 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar